Serious Asthma Events with Fluticasone plus Salmeterol versus Fluticasone Alone.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  New England Journal of Medicine

• Publication date

  2016-03-06

• Fields of study

  Medicine

• Identifiers
  DOI 10.1056/NEJMoa1511049PMID 26949137
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Asthma exacerbation rates in adults are unchanged over a 5-year period despite high-intensity therapy.

  2014cited by this paper
• Dispensation of long-acting β agonists with or without inhaled corticosteroids, and risk of asthma-related hospitalisation: a population-based study

  2013cited by this paper
• Once-daily fluticasone furoate (FF)/vilanterol reduces risk of severe exacerbations in asthma versus FF alone

  2013cited by this paper
• National surveillance of asthma: United States, 2001-2010.

  2012cited by this paper
• Age and Risks of FDA-Approved Long-Acting β2-Adrenergic Receptor Agonists

  2011cited by this paper
• An update on the safety of long-acting β-agonists in asthma patients using inhaled corticosteroids

  2010cited by this paper
• The FDA and safe use of long-acting beta-agonists in the treatment of asthma.

  2010cited by this paper
• Safety of formoterol in patients with asthma: combined analysis of data from double-blind, randomized controlled trials.

  2010cited by this paper
• The use of beta agonists and the risk of death and near death from asthma.

  2009cited by this paper
• An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice.

  2009cited by this paper
• Meta-analysis of the risk of mortality with salmeterol and the effect of concomitant inhaled corticosteroid therapy

  2009cited by this paper
• Meta-analysis: Effects of Adding Salmeterol to Inhaled Corticosteroids on Serious Asthma-Related Events

  2008cited by this paper
• Regular treatment with formoterol for chronic asthma: serious adverse events.

  2008cited by this paper
• Regular treatment with salmeterol for chronic asthma: serious adverse events.

  2008cited by this paper
• Effect of budesonide/formoterol maintenance and reliever therapy on asthma exacerbations

  2007cited by this paper
• The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol.

  2006cited by this paper
• Meta-Analysis: Effect of Long-Acting -Agonists on Severe Asthma Exacerbations and Asthma-Related Deaths

  2006cited by this paper
• Group Sequential Methods with Applications to Clinical Trials

  2001cited by this paper
• Development and validation of a questionnaire to measure asthma control.

  1999cited by this paper
• Potential masking effects of salmeterol on airway inflammation in asthma.

  1998cited by this paper
• GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION

  1996cited by this paper
• A cohort analysis of excess mortality in asthma and the use of inhaled beta-agonists.

  1994cited by this paper
• Is the association between inhaled beta-agonist use and life-threatening asthma because of confounding by severity?

  1993cited by this paper
• Serevent nationwide surveillance study: comparison of salmeterol with salbutamol in asthmatic patients who require regular bronchodilator treatment.

  1993cited by this paper
• The Use of β-Agonists and the Risk of Death and near Death from Asthma

  1992cited by this paper
• The use of beta-agonists and the risk of death and near death from asthma.

  1992cited by this paper
• Prescribed fenoterol and death from asthma in New Zealand, 1981-83: case-control study.

  1989cited by this paper
• Observations on recent increase in mortality from asthma.

  1968cited by this paper

• Pharmacoeconomic evaluation of ICS-LABA therapy in pediatric asthma: a cost-effectiveness and cost-utility analysis

  2025cites this paper
• Cardiovascular Risk of the Use of Long-acting Bronchodilators in Patients with Asthma: A Meta-analysis of 22 Randomized Controlled Trials.

  2025cites this paper
• Establishing the best step-up treatments for children with uncontrolled asthma despite inhaled corticosteroids: the EINSTEIN systematic review, network meta-analysis and cost-effectiveness analysis using individual participant data.

  2025cites this paper
• The Role of ICS-containing Rescue Therapy versus SABA Alone in Asthma Management Today.

  2024cites this paper
• Observational studies to emulate randomized trials: Some real‐world barriers

  2024cites this paper
• Asthma management with triple ICS/LABA/LAMA combination to reduce the risk of exacerbation: an umbrella review compliant with the PRIOR statement

  2024cites this paper
• The Wiser Strategy of Using Beta-Agonists in Asthma: Mechanisms and Rationales

  2024cites this paper
• Differences in the effectiveness of single, dual, and triple inhaled corticosteroid therapy for reducing future risk of severe asthma exacerbation: A systematic review and network meta-analysis

  2024cites this paper
• Effect of Individual Patient Characteristics and Treatment Choices on Reliever Medication Use in Moderate-Severe Asthma: A Poisson Analysis of Randomised Clinical Trials

  2024cites this paper
• Modelling ASthma TrEatment Responses (MASTER): Effect of individual patient characteristics on the risk of exacerbation in moderate or severe asthma: A time‐to‐event analysis of randomized clinical trials

  2023cites this paper
• Is the assessment of asthma treatment efficacy sufficiently comprehensive?

  2023cites this paper
• Systematic literature review of traits and outcomes reported in randomised controlled trials of asthma with regular dosing of inhaled corticosteroids with short-acting β2-agonist reliever, as-needed ICS/formoterol, or ICS/formoterol maintenance and reliever therapy.

  2023cites this paper
• Best step-up treatments for children with uncontrolled asthma: a systematic review and network meta-analysis of individual participant data

  2023cites this paper
• Efficacy and safety of fluticasone propionate/salmeterol and fluticasone propionate monotherapy in step-up treatment of childhood asthma: A systematic review and meta-analysis.

  2023cites this paper
• Maintenance Therapy for Children and Adolescents with Asthma: Guidelines and Recommendations from the Emilia-Romagna Asthma (ERA) Study Group

  2023cites this paper
• Addition of long-acting beta2 agonists or long-acting muscarinic antagonists versus doubling the dose of inhaled corticosteroids (ICS) in adolescents and adults with uncontrolled asthma with medium dose ICS: a systematic review and network meta-analysis.

  2023cites this paper
• Understanding the Clinical Implications of Individual Patient Characteristics and Treatment Choice on the Risk of Exacerbation in Asthma Patients with Moderate–Severe Symptoms

  2023cites this paper
• Immunogenetics and pharmacogenetics of allergic asthma in Africa

  2023cites this paper
• Advances in Evaluation and Treatment of Severe Asthma (Part One).

  2022cites this paper
• Effectiveness and Treatment Compliance of Salmeterol–Fluticasone Easyhaler® Among Patients with Asthma, COPD, or Asthma–COPD Overlap Syndrome: Real-World Study Findings

  2022cites this paper
• Advances in Evaluation and Treatment of Severe Asthma (Part Two).

  2022cites this paper
• Praktische Gesichtspunkte der Asthmatherapie mit Fixkombination und „single inhaler maintenance and reliever therapy“ (SMART) bei Kindern und Jugendlichen

  2022influential citation
• Recent advances on synthesis and biological activities of C-17 aza-heterocycle derived steroids.

  2022cites this paper
• An assessment of asthma exacerbations in pediatric patients using a long-acting B2-agonist plus inhaled corticosteroid versus an inhaled corticosteroid alone

  2022cites this paper
• Steroid-induced fibroblast growth factors drive an epithelial-mesenchymal inflammatory axis in severe asthma

  2022cites this paper
• Insights from the AUSTRI study on reliever use before and after asthma exacerbations.

  2022cites this paper
• Asthma Inhaler Adherence in Adults: a Rapid Systematic Review with Meta-analysis

  2022cites this paper
• New Versus Old: The Impact of Changing Patterns of Inhaled Corticosteroid Prescribing and Dosing Regimens in Asthma Management

  2022cites this paper
• Primary Care Management of Asthma Exacerbations or Attacks: Impact of the COVID-19 Pandemic

  2022cites this paper
• [Update of the 2021 Recommendations for the management of and follow-up of adolescent asthmatic patients (over 12 years) under the guidance of the French Society of Pulmonology and the Paediatric Society of Pulmonology and Allergology. Long version].

  2022cites this paper
• Direct healthcare costs associated with management of asthma: comparison of two treatment regimens in Indonesia, Thailand and Vietnam

  2021cites this paper
• Cardiovascular safety of mometasone/indacaterol and mometasone/indacaterol/glycopyrronium once-daily fixed-dose combinations in asthma: pooled analysis of phase 3 trials.

  2021cites this paper
• Safety of As-Needed Budesonide-Formoterol in Mild Asthma: Data from the Two Phase III SYGMA Studies

  2021cites this paper
• Safety of anti-inflammatory drugs in children with asthma.

  2021cites this paper
• A Pilot Study of Daily Fluticasone Propionate and Episodic Salmeterol/ Fluticasone Propionate in Childhood Asthma

  2021cites this paper
• Difficult-to-treat Asthma Management in School-Age Children.

  2021cites this paper
• A non-interventional switch study in adult patients with asthma or COPD on clinical effectiveness of salmeterol/fluticasone Easyhaler® in routine clinical practice

  2021cites this paper
• Pragmatic randomized controlled trial for stepping down of asthma controller treatment in patients controlled with low dose inhaled corticosteroid and long-acting beta2 agonist: SIGMA study.

  2021cites this paper
• Regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmeterol and an inhaled corticosteroid for chronic asthma: serious adverse events.

  2021cites this paper
• Uncovering Outcome Disparities of β2 Adrenergic Agonists in Blacks: A Systematic Review.

  2020cites this paper
• β2-Agonists in Asthma: The Strange case of Dr. Jekyll and Mr. Hyde.

  2020cites this paper
• Pharmacotherapeutic management of asthma in the elderly patient

  2020cites this paper
• Difficult To Treat Asthma: Clinical Essentials

  2020cites this paper
• Letter to the editor - serious asthma events with fluticasone plus salmeterol versus fluticasone alone

  2020cites this paper
• What have we learnt about asthma control from trials of budesonide/formoterol as maintenance and reliever?

  2020cites this paper
• Adherence to Adding Inhaled Corticosteroids to Rescue Therapy in a Pragmatic Trial with Adults with Asthma- a Pilot Study.

  2020cites this paper
• β2-agonists in asthma: the strange case of Dr Jekyll and Mr Hyde

  2020cites this paper
• Serious Asthma Outcomes and Asthma Exacerbations with Maintenance on Inhaled Corticosteroid (Mometasone Furoate)/Long-Acting Beta Agonist (Formoterol) Combination Compared to Step Down to Mometasone Monotherapy.

  2020cites this paper
• Effectiveness and tolerability of dual and triple combination inhaler therapies compared with each other and varying doses of inhaled corticosteroids in adolescents and adults with asthma: a systematic review and network meta-analysis.

  2020cites this paper
• Efficacy and safety of inhaled nebulized sodium nitrite in asthmatic patients.

  2020cites this paper
• Difficult and Severe Asthma in Children

  2020cites this paper
• Recent Advances in β2-Agonists for Treatment of Chronic Respiratory Diseases and Heart Failure.

  2020cites this paper
• Comparison of Two Therapies on Asthma Control in Children

  2020cites this paper
• 2020 Brazilian Thoracic Association recommendations for the management of asthma

  2020influential citation
• Inhaled corticosteroids as treatment for adolescent asthma: effects on adult anxiety-related outcomes in a murine model

  2020cites this paper
• Management of Medication Side Effects and Complications

  2019cites this paper
• General practitioners' views on the influence of cost on the prescribing of asthma preventer medicines: a qualitative study.

  2019cites this paper
• Clinical Approach to the Therapy of Asthma‐COPD Overlap

  2019cites this paper
• Strategies to prevent exacerbations of childhood asthma

  2019cites this paper
• Serious asthma events with mometasone furoate plus formoterol compared with mometasone furoate

  2019cites this paper
• The Asthma Controller Step-down Yardstick.

  2019cites this paper
• The efficacy and safety of fluticasone/salmeterol compared to fluticasone in children younger than four years of age

  2019cites this paper
• ADRB2 p.Thr164Ile association with hospitalization depends upon asthma severity.

  2019cites this paper
• Two Sides of the Same Coin?—Treatment of Chronic Asthma in Children and Adults

  2019cites this paper
• Combination of inhaled corticosteroid and a long-acting β-agonist: Proceed with caution.

  2019cites this paper
• Author response.

  2019cites this paper
• Changes in Persistent Asthma Care and Outcomes From 2006 to 2016 in France.

  2019cites this paper
• Loss of bronchoprotection with ICS plus LABA treatment, β-receptor dynamics, and the effect of alendronate.

  2019cites this paper
• [New approaches of inhaled steroid asthma management in mild to moderate asthma].

  2019cites this paper
• Personalized Medicine and Pediatric Asthma.

  2019cites this paper
• Seasonal variation in asthma exacerbations in the AUSTRI and VESTRI studies

  2019cites this paper
• Severe asthma: mechanisms in children

  2019cites this paper
• The beta adrenergic theory of bronchial asthma: 50 years later.

  2019cites this paper
• Advances in Inhaled Medications

  2019cites this paper
• Severe Asthma in Childhood: Special Considerations

  2019cites this paper
• Exacerbation of ozone-induced pulmonary and systemic effects by β2-adrenergic and/or glucocorticoid receptor agonist/s

  2019cites this paper
• Effects of short- and long-acting beta-agonists on asthma exacerbations: a prospective cohort.

  2019cites this paper
• Inhaled Corticosteroid Therapy for Asthma

  2019cites this paper
• Pulmonary Pharmacology

  2019cites this paper
• Asthma

  2019cites this paper
• Food and Drug Administration‐mandated Trials of Long‐Acting &bgr;‐Agonist Safety in Asthma. Bang for the Buck?

  2018cites this paper
• Efficacy and safety of the combination fluticasone propionate plus salmeterol in asthmatic preschoolers: An observational study

  2018cites this paper
• Controlling the Risk Domain in Pediatric Asthma through Personalized Care

  2018cites this paper
• FDA-Approved Indication for Triple Combination Agent Indication Trelegy Ellipta

  2018cites this paper
• The cost of asthma medicines.

  2018cites this paper
• The Tempest: Difficult to Control Asthma in Adolescence.

  2018cites this paper
• Asthma Over the Age of 65: All's Well That Ends Well.

  2018cites this paper
• Drug Development for Asthma and COPD: A Regulatory Perspective

  2018cites this paper
• Clinical Pharmacology of Bronchodilator Medications

  2018cites this paper
• The Health and Economic Outcomes of Peanut Allergy Management Practices.

  2018cites this paper
• &bgr;2‐Agonists Enhance Asthma‐Relevant Inflammatory Mediators in Human Airway Epithelial Cells

  2018cites this paper
• Management of Severe Asthma in Children

  2018cites this paper
• Combined Analysis of Asthma Safety Trials of Long‐Acting β2‐Agonists

  2018cites this paper
• The pediatric asthma yardstick: Practical recommendations for a sustained step-up in asthma therapy for children with inadequately controlled asthma.

  2018cites this paper
• Challenges in the treatment of asthma in children and adolescents.

  2018cites this paper
• Chapter 4 – Management and Prevention of Severe Asthma in Children

  2018cites this paper
• Новые возможности терапии бронхиальной астмы у детей

  2018cites this paper
• The guidelines of asthma: the boon and the bane

  2018cites this paper
• Bronchodilator Therapy for Asthma

  2018cites this paper
• What’s new in the Global Initiative for Asthma 2018 report and beyond

  2018cites this paper